Quality Care

How Are Non-Medical CEOs Reshaping Malaysian Healthcare?
Organizational Governance How Are Non-Medical CEOs Reshaping Malaysian Healthcare?

The traditional hierarchy within Malaysian medical institutions is undergoing a silent yet profound metamorphosis as business-trained executives replace clinical practitioners at the helm of the country's most prestigious private hospitals. This structural shift marks a departure from the

Can Included Health and Firefly Disrupt Health Insurance?
Care Can Included Health and Firefly Disrupt Health Insurance?

The traditional American employer-sponsored healthcare model, long criticized for its opacity and escalating costs, is currently facing a fundamental challenge as tech-driven innovators consolidate their power to offer direct alternatives to legacy carriers. Included Health's recent

AI Voice Agents in Healthcare to Reach $10.4 Billion by 2036
Technology AI Voice Agents in Healthcare to Reach $10.4 Billion by 2036

The traditional image of a physician hunched over a keyboard while a patient shares intimate health concerns is rapidly becoming a relic of a less efficient era in global medicine. As the healthcare industry transitions away from the stifling constraints of manual data entry and screen-heavy

How Mature Is Your Iodine Contrast Stewardship Strategy?
Organizational Governance How Mature Is Your Iodine Contrast Stewardship Strategy?

The current landscape of diagnostic imaging is defined by a paradoxical relationship between increasing clinical demand and the inherent fragility of the global supply chain for iodinated contrast media. As the volume of computed tomography scans continues to rise across every major medical

MIT Develops Portable 3D Ultrasound for Breast Cancer Screening
Care MIT Develops Portable 3D Ultrasound for Breast Cancer Screening

The persistent threat posed by aggressive malignancies that emerge between scheduled clinical screenings, known as interval cancers, remains one of the most significant challenges in modern oncology today. These rapidly growing tumors account for nearly thirty percent of all breast cancer diagnoses

Can KRAS Inhibitors Stop Cancer Before It Starts?
Care Can KRAS Inhibitors Stop Cancer Before It Starts?

The medical landscape is currently undergoing a radical transformation as oncologists pivot from reactive treatments to proactive strategies that target genetic mutations before they manifest as symptomatic disease. For years, the KRAS gene was considered an impossible target, a biological

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later